Highlights of NCCN/AUA Guidelines 2024
Siamak Daneshmand, MD, covers recent updates in bladder cancer guidelines, focusing on the 2024 NCCN and AUA recommendations.
Read More
International Bladder Cancer Update
Role of Systemic Therapies in NMIBC
Amirali Salmasi, MD, MSCR, explores the rationale for systemic immunotherapy in non-muscle invasive bladder cancer.
Read More
Role of CtDNA in Bladder Cancer
Alexandra Drakaki, MD, PhD, explores circulating tumor DNA in bladder cancer, highlighting its potential as a biomarker.
Read More
Role of DNA Repair Mutations in Sensitivity to Cisplatin-based Chemotherapy
Gopalkumar Iyer, MD, explores the role of genomic alterations in predicting response to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Read More
Role of PLND for High Risk Bladder Cancer
Bernard H. Bochner, MD, FACS, examines the extent of lymph node dissection in bladder cancer surgery and its impact on oncologic outcomes.
Read More